Assembly Biosciences, Inc. (ASMB) Net income 2016–2025
Assembly Biosciences, Inc. (ASMB) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$6.1MFY2025 · since FY2016: -$44.3M → -$6.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.1M | +84.8% |
| FY2024 | -$40.2M | +34.4% |
| FY2023 | -$61.2M | +34.2% |
| FY2022 | -$93.1M | +28.3% |
| FY2021 | -$129.9M | -108.9% |
| FY2020 | -$62.2M | +36.3% |
| FY2019 | -$97.6M | -7.6% |
| FY2018 | -$90.8M | -112.0% |
| FY2017 | -$42.8M | +3.3% |
| FY2016 | -$44.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ASMB financial trends
ASMB RevenueASMB Net marginASMB Gross profitASMB Gross marginASMB Operating incomeASMB Operating marginASMB Operating cash flowASMB Free cash flowASMB Capital expendituresASMB Return on equityASMB Stock buybacksASMB Dividends paidASMB Total assetsASMB Total liabilitiesASMB Shareholders’ equityASMB overview →